https://doi.org/10.4081/ejtm.2026.14718
Does GABA supplementation modulate muscle cytokine expression and inflammatory status in aged rats?
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 10 February 2026
Aging is a multifactorial process affecting all organs and systems in the body. Specific to aging is the establishment of a chronic subacute inflammatory state in tissues underlying age-related pathologies. GABA (Gamma-Aminobutyric Acid) is an inhibitory neurotransmitter in the central nervous system. Pharmaceutical properties of Gaba on non-neuronal peripheral tissues and organs were reported from anti-hypertension, anti-diabetes, anti-cancer, antioxidant, anti-inflammation, anti-microbial, anti-allergy, hepato-protection, reno-protection, and intestinal protection. GABA was indicated as an inflamation inhibitor via decreasing pro-inflammatory mediator production and ameliorating inflammatory symptoms. This study aimed to evaluate the effect of GABA supplementation on inflammatory status in the muscle tissue of aged rats. Male Wistar rats (n=24) were put in 3 groups: CY (3 month-old controls); CO (24 month-old controls); G (24 month-old rats supplemented with GABA at dosage of 10ml/kg for 3 months). At the experiment's end, skeletal muscle, small intestine and heart material was collected for immunohistochemical analysis. Comparative analysis of the intensity of IL-10, IL-4 and IL-1β immunoreaction in different muscle tissues showed that inflammatory responses varied with age and tissue. Aged animals showed higher IL-1β levels than young animals, and these effects amplified in IL-10- and IL-4-deficient rat muscles of same group. In group of GABA-supplemented animals, the intensity of IL-1β in skeletal muscle, heart and small intestine was reduced compared to adult controls. In conclusion, GABA supplementation can influence the inflammatory status of muscle tissue in old animals by modulating pro- and anti-inflammatory cytokine levels. GABA can be used to prevent the effects of ageing.
Downloads
1. Ngo D, Vo T. An updated review on pharmaceutical properties of gamma-aminobutyric acid. Molecules 2019;24:2678.
2. Baldo BA. Cytokines. Safety Biologics Ther 2016;13:217-61.
3. Akdis M, Aab A, Altunbulakli C, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2016;138:984-1010.
4. Li B, Cheung PCK. The immunoregulatory role of interleukin-4 in immune responses. J Cell Physiol 2019;234:4217-4227.
5. Ouyang W, O’Garra A. IL-10 family cytokines: from basic biology to disease therapy. Immunity 2019;50:871-891.
6. Fu J, Han Z, Wu Z, et al. GABA regulates IL-1β production in macrophages. Cell Rep 2022;41:111770.
7. Xia Y, He F, Wu X, et al. GABA transporter sustains IL-1β production in macrophages. Sci Adv 2021;7:eabe9274.
8. Narayan P, Trikantzopoulos E, Mezzaroma E, Mauro A, Vohra H, Abbate A, Toldo S. The interleukin-1 re- ceptor type I promotes the development of aging-associated cardiomyopathy in mice. Cytokine 2022;151:155811.
9. Ngo DH, Tran QT, Kim YS, Hang NTN, Ngo DN, Vo TS. GABA-enriched rice bran inhibits inflammation in LPS-stimulated macrophages via suppression of TLR4-MAPK/NF-κB signaling cascades. J Food Bio- chem. 2022;46(12):e14421
10. Tian J, Lu Y, Zhang H, Chau CH, Dang HN, Kaufman DL. Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 2004;173:5298-304.
11. Park J, Lee H. GABA receptor involvement in skeletal muscle regeneration. Cells 2020;9:1324.
12. Benarroch EE. Muscle immune–metabolic interactions and aging. Neurology 2020;95:705-14.
13. Bhandage AK, Barragan A. GABAergic signaling in gut immunity and inflammation. Front Immunol 2022;13:1020053.
14. Deng Z, Li D, Wang L, et al. Activation of GABA-BR attenuates intestinal inflammation by reducing oxidative stress through modulating the TLR4/MyD88/NLRP3 pathway and gut microbiota abundance. Antioxidants 2024;13:1141.
15. Tian J, Kaufman DL. The GABA and GABA-receptor system in inflammation, anti-tumor immune responses, and COVID-19. Biomedicines 2023;11:254.
16. Llansola M, Arenas YM, Sancho-Alonso M, et al. Neuroinflammation alters GABAergic neurotransmission in hyperammonemia and hepatic encephalopathy. Front Pharmacol 2024;15:1358323.
17. Song G, Oh HJ, Jin H, et al. GABA prevents sarcopenia by regulation of muscle protein degradation and inflammaging in aged mice. J Cachexia Sarcopenia Muscle 2024;15:2852-64.
18. Ji Y, Li M, Chang M, et al. Inflammation: roles in skeletal muscle atrophy. Antioxidants 2022;11:1686.
19. Jin H, Oh HJ, Lee BY. GABA prevents age-related sarcopenic obesity in mice with high-fat-diet-induced obesity. Cells 2023;12:2146.
20. Liu Q, Li Y, Shi Y, et al. Protective effect of GABA-B receptor activation on sympathetic nerve remodeling via regulation of M2 macrophage polarization after myocardial infarction. Rev Port Cardiol 2023;42:125-35.
21. Horii M, Bumrungkit C, Yanaka N, et al. Effects of oral γ-aminobutyric acid intake on muscle regeneration in diabetic mice. Am J Physiol Cell Physiol 2025;328:C967-85.
CRediT authorship contribution
The authors contributed equally to the present paper.
Supporting Agencies
This work was funded by project KP-06-N71/46 of the Bulgarian National Science Fund.How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.